LUNOVUS, LLC – Trademark Portfolio
Entity Type: 16
LUNOVUS, LLC holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include LUNOVUS, BLEPHADEX, MAXITEARS, MAXIVISION, and LUNOVUS VISUAL ADVANTAGE. The owner is based in Morris, AL.
8289 Highway 31 N
Morris, AL 35116
Showing of trademarks Trademarks
Trademark Classifications
LUNOVUS, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does LUNOVUS, LLC have?
LUNOVUS, LLC has 11 U.S. trademarks filed with the USPTO. Of these, 7 registered, 3 abandoned, 1 cancelled.
What trademark classes does LUNOVUS, LLC file in?
LUNOVUS, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning), Class 39 (Transportation & Storage). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are LUNOVUS, LLC's most well-known trademarks?
LUNOVUS, LLC's registered trademark portfolio includes well-known marks such as LUNOVUS, BLEPHADEX, MAXITEARS, MAXIVISION, and LUNOVUS VISUAL ADVANTAGE. These are among 7 currently registered trademarks in the portfolio.
What is LUNOVUS, LLC's trademark registration success rate?
LUNOVUS, LLC has a 64% trademark registration rate, with 7 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.